Saturday, October 4, 2025
HomeTagsBiopharmaceutical

biopharmaceutical

Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy

Roche, announced that it has entered into a definitive merger agreement to acquire 89bio, a publicly listed clinical-stage biopharmaceutical company pioneering the development of...

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the appointment of Rajat Mehta as its new Executive Vice...

Novartis Acquire Regulus Therapeutics

Novartis announced the successful completion of its acquisition of Regulus Therapeutics, a clinical-stage biopharmaceutical company pioneering oligonucleotide therapies. With this milestone, Regulus becomes an...

Sanofi Acquires Blueprint Medicines to Boost Immunology Pipeline

Sanofi announced a definitive agreement to acquire Blueprint Medicines Corporation, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and other KIT-driven diseases. This...

Sanofi completes acquisition of Dren Bio’s DR-0201

Sanofi announced the successful completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, a privately held, clinical-stage biopharmaceutical...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics